Japan approves morning after pill for over the counter sale

The ‘morning-after pill’ is intended to prevent pregnancy after unprotected sex. Japan has now given approval to sell it over the counter.

Japan approves morning after pill for over the counter sale

Japan has approved an emergency contraceptive pill to be taken without a prescription for the first time.

Local media reports the drug won’t have age restrictions or need parental consent.

The pill will be rolled out nation-wide following a trial that began in 2023.

Here’s what you need to know.

ECP

The emergency contraceptive pill (ECP), also known as the ‘morning after pill’, is intended to prevent pregnancy after unprotected sex.

The World Health Organisation classifies ECPs as “essential medicines”.

They are available over the counter in 90 countries, including Australia.

Norlevo

The Japanese Government has now given pharmaceutical company ASKA approval to sell its drug Norlevo over the counter.

The medication previously required a prescription.

You have read 0 articles this year.

Your contribution ensures The Daily Aus can continue doing the work you love.

Local outlet Mainichi Japan reports there are no age restrictions or need for parental consent, but the medication must be taken in front of a pharmacist.

It’s not yet clear when the medication will be rolled out.

Japan

The latest Global Gender Gap report ranks Japan 118th out of 148 countries, finding Japanese women have restricted reproductive rights.

Japan approved its first oral contraceptive drug in 1999 and medical abortions in 2023.

Most Western countries, including Australia, approved oral contraceptives in the 1960s.

Japanese law requires women seeking an abortion to get their partner’s consent in most cases.

History

The Japanese Government had discussed allowing access to emergency contraceptives without a prescription on multiple occasions in the past.

In 2017, officials denied the proposal based on the possibility it would encourage “irresponsible” use. A 2022 Government survey received more than 46,000 submissions, with 97% being in favour.

The country has trialled over the counter ECPs for women aged 16 and above at some pharmacies since late 2023.

Get Australia's free morning news brief.

Trusted by 400,000 Australians. Free, every weekday.

Already subscribed? Just enter your email above. Privacy Policy.